Sung Yong Oh
Dong-a University
202 Papers
1.1K Citations
Sung Yong Oh is an academic researcher from Dong-a University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 34, co-authored 183 publications. Previous affiliations of Sung Yong Oh include Dong-A University Hospital.
Chat about Author
Papers
Practice patterns of multidisciplinary team meetings in Korean cancer care and patient satisfaction with this approach
TL;DR: The application of MDT care is a rapidly growing trend in clinical oncology, and shows high patient satisfaction, and further research is needed to determine which types of cancer patients could benefit most from MDT, and to enableMDT care to operate more efficiently.
Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.
Sung Yong Oh,Cheolwon Suh +1 more
TL;DR: This work focuses on non-gastric MZL studies conducted in Korea that highlight the most recent advances with respect to MZZL definition, etiology, clinical characteristics, natural history, treatment approaches, outcomes, and prognostic factors.
Prognostic significance of serum levels of vascular endothelial growth factor and insulin-like growth factor-1 in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Sung Yong Oh,Hyuk-Chan Kwon,Sung Hyun Kim,Suee Lee,Ji Hyun Lee,Christian A. Graves,Kevin Camphausen,Hyojin Kim +7 more
TL;DR: A high level of serum VEGF is an independent prognostic factor in patients with advanced gastric cancer treated with chemotherapy, and may help to identify the patients who are more sensitive to the FOLFOX regimen.
Identification of genes underlying different methylation profiles in refractory anemia with excess blast and refractory cytopenia with multilineage dysplasia in myelodysplastic syndrome
Suee Lee,Hyuk-Chan Kwon,Sung-Hyun Kim,Sung Yong Oh,Ji Hyun Lee,Yeon-Su Lee,Daekwan Seo,Jin-Yeong Han,Hyo-Jin Kim +8 more
TL;DR: DNA methylation of GSTM5, BIK, and ANGPTL2 may induce epigenetic silencing and contribute to the increasing blasts and resulting MDS progression; however, the functions of these genes were not determined.
Capecitabine monotherapy and the clinical significance of neutrophil-lymphocyte ratio versus platelet-lymphocyte ratio in patients with metastatic colorectal cancer.
Suee Lee,Hyukchan Kwon,Sunghyun Kim,Sung Yong Oh,Ji Hyun Lee,Hyun-Hwa Yoon,Hongjo Choi,Hyo-Jin Kim +7 more
TL;DR: The capecitabine monotherapy showed a moderate disease control and a tolerable toxicity profile and may be simple and useful prognostic index for metastatic colorectal cancer.
10